Eventide Asset Management, LLC Horizon Therapeutics Public LTD CO Transaction History

Eventide Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$98.98 - $115.74 $2,375 - $2,777	24 Added 0.0%	689,732 $79.8 Million
Q2 2023 Aug 15, 2023	SELL	$96.34 - $112.38 $10.7 Million - $12.4 Million	-110,743 Reduced 13.84%	689,708 $70.9 Million
Q1 2023 May 15, 2023	SELL	$107.32 - $113.5 $21 Million - $22.2 Million	-195,749 Reduced 19.65%	800,451 $87.4 Million
Q4 2022 Feb 13, 2023	BUY	$62.39 - $113.8 $1.56 Million - $2.85 Million	25,000 Added 2.57%	996,200 $113 Million
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $53.1 Million - $76.3 Million	901,400 Added 1291.4%	971,200 $60.1 Million

Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $5.54 Million - $8.12 Million	69,800 New	69,800 $5.57 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Eventide Asset Management, LLC with notifications on news.